Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A special diet can help manage Feline Atopic Skin Syndrome and reduce medication needs in cats.

Methotrexate may help stabilize frontal fibrosing alopecia.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Frunevetmab injections in cats can cause severe itching and skin lesions.

A reliable method was created to measure tamsulosin in human blood.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

The two finasteride tablets are bioequivalent.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.